175 related articles for article (PubMed ID: 26762151)
1. Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach.
Sundaram N; Schaetti C; Merten S; Schindler C; Ali SM; Nyambedha EO; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
BMC Public Health; 2016 Jan; 16():36. PubMed ID: 26762151
[TBL] [Abstract][Full Text] [Related]
2. Comparing sociocultural features of cholera in three endemic African settings.
Schaetti C; Sundaram N; Merten S; Ali SM; Nyambedha EO; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
BMC Med; 2013 Sep; 11():206. PubMed ID: 24047241
[TBL] [Abstract][Full Text] [Related]
3. Social and cultural determinants of anticipated acceptance of an oral cholera vaccine prior to a mass vaccination campaign in Zanzibar.
Schaetti C; Chaignat CL; Hutubessy R; Khatib AM; Ali SM; Schindler C; Weiss MG
Hum Vaccin; 2011 Dec; 7(12):1299-308. PubMed ID: 22108036
[TBL] [Abstract][Full Text] [Related]
4. Local perceptions of cholera and anticipated vaccine acceptance in Katanga province, Democratic Republic of Congo.
Merten S; Schaetti C; Manianga C; Lapika B; Chaignat CL; Hutubessy R; Weiss MG
BMC Public Health; 2013 Jan; 13():60. PubMed ID: 23339647
[TBL] [Abstract][Full Text] [Related]
5. Socio-cultural determinants of anticipated acceptance of an oral cholera vaccine in Western Kenya.
Sundaram N; Schaetti C; Chaignat CL; Hutubessy R; Nyambedha EO; Mbonga LA; Weiss MG
Epidemiol Infect; 2013 Mar; 141(3):639-50. PubMed ID: 22564277
[TBL] [Abstract][Full Text] [Related]
6. Social and cultural determinants of oral cholera vaccine uptake in Zanzibar.
Schaetti C; Ali SM; Hutubessy R; Khatib AM; Chaignat CL; Weiss MG
Hum Vaccin Immunother; 2012 Sep; 8(9):1223-9. PubMed ID: 22894965
[TBL] [Abstract][Full Text] [Related]
7. Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance.
Schaetti C; Hutubessy R; Ali SM; Pach A; Weiss MG; Chaignat CL; Khatib AM
BMC Public Health; 2009 Apr; 9():99. PubMed ID: 19351401
[TBL] [Abstract][Full Text] [Related]
8. Improving community coverage of oral cholera mass vaccination campaigns: lessons learned in Zanzibar.
Schaetti C; Ali SM; Chaignat CL; Khatib AM; Hutubessy R; Weiss MG
PLoS One; 2012; 7(7):e41527. PubMed ID: 22844489
[TBL] [Abstract][Full Text] [Related]
9. Social and cultural features of cholera and shigellosis in peri-urban and rural communities of Zanzibar.
Schaetti C; Khatib AM; Ali SM; Hutubessy R; Chaignat CL; Weiss MG
BMC Infect Dis; 2010 Nov; 10():339. PubMed ID: 21110853
[TBL] [Abstract][Full Text] [Related]
10. Sociocultural determinants of anticipated vaccine acceptance for acute watery diarrhea in early childhood in Katanga Province, Democratic Republic of Congo.
Merten S; Schaetti C; Manianga C; Lapika B; Hutubessy R; Chaignat CL; Weiss M
Am J Trop Med Hyg; 2013 Sep; 89(3):419-25. PubMed ID: 23878187
[TBL] [Abstract][Full Text] [Related]
11. Use of Oral Cholera Vaccine and Knowledge, Attitudes, and Practices Regarding Safe Water, Sanitation and Hygiene in a Long-Standing Refugee Camp, Thailand, 2012-2014.
Scobie HM; Phares CR; Wannemuehler KA; Nyangoma E; Taylor EM; Fulton A; Wongjindanon N; Aung NR; Travers P; Date K
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005210. PubMed ID: 27992609
[TBL] [Abstract][Full Text] [Related]
12. A rapid qualitative assessment of oral cholera vaccine anticipated acceptability in a context of resistance towards cholera intervention in Nampula, Mozambique.
Démolis R; Botão C; Heyerdahl LW; Gessner BD; Cavailler P; Sinai C; Magaço A; Le Gargasson JB; Mengel M; Guillermet E
Vaccine; 2018 Oct; 36(44):6497-6505. PubMed ID: 29174106
[TBL] [Abstract][Full Text] [Related]
13. Current and future cholera vaccines.
Shaikh H; Lynch J; Kim J; Excler JL
Vaccine; 2020 Feb; 38 Suppl 1():A118-A126. PubMed ID: 31879125
[TBL] [Abstract][Full Text] [Related]
14. Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar.
Schaetti C; Weiss MG; Ali SM; Chaignat CL; Khatib AM; Reyburn R; Duintjer Tebbens RJ; Hutubessy R
PLoS Negl Trop Dis; 2012; 6(10):e1844. PubMed ID: 23056660
[TBL] [Abstract][Full Text] [Related]
15. Cholera vaccination campaign contributes to improved knowledge regarding cholera and improved practice relevant to waterborne disease in rural Haiti.
Aibana O; Franke MF; Teng JE; Hilaire J; Raymond M; Ivers LC
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2576. PubMed ID: 24278498
[TBL] [Abstract][Full Text] [Related]
16. Highly targeted cholera vaccination campaigns in urban setting are feasible: The experience in Kalemie, Democratic Republic of Congo.
Massing LA; Aboubakar S; Blake A; Page AL; Cohuet S; Ngandwe A; Mukomena Sompwe E; Ramazani R; Allheimen M; Levaillant P; Lechevalier P; Kashimi M; de la Motte A; Calmejane A; Bouhenia M; Dabire E; Bompangue D; Kebela B; Porten K; Luquero F
PLoS Negl Trop Dis; 2018 May; 12(5):e0006369. PubMed ID: 29734337
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi.
Msyamboza KP; M'bang'ombe M; Hausi H; Chijuwa A; Nkukumila V; Kubwalo HW; Desai S; Pezzoli L; Legros D
Pan Afr Med J; 2016; 23():203. PubMed ID: 27347292
[TBL] [Abstract][Full Text] [Related]
18. Feasibility, coverage and cost of oral cholera vaccination conducted by icddr,b using the existing national immunization service delivery mechanism in rural setting Keraniganj, Bangladesh.
Khan AI; Khan IA; Siddique SA; Rahman A; Islam MT; Bhuiya MAI; Saha NC; Biswas PK; Saha A; Chowdhury F; Qadri F
Hum Vaccin Immunother; 2019; 15(6):1302-1309. PubMed ID: 30261152
[No Abstract] [Full Text] [Related]
19. Socioeconomic drivers of vaccine uptake: An analysis of the data of a geographically defined cluster randomized cholera vaccine trial in Bangladesh.
Saha A; Hayen A; Ali M; Rosewell A; MacIntyre CR; Clemens JD; Qadri F
Vaccine; 2018 Jul; 36(31):4742-4749. PubMed ID: 29752024
[TBL] [Abstract][Full Text] [Related]
20. Global oral cholera vaccine use, 2013-2018.
Pezzoli L;
Vaccine; 2020 Feb; 38 Suppl 1(Suppl 1):A132-A140. PubMed ID: 31519444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
